[go: up one dir, main page]

SG11201707776UA - A fast acting orally disintegrating film for administration of local anesthesia - Google Patents

A fast acting orally disintegrating film for administration of local anesthesia

Info

Publication number
SG11201707776UA
SG11201707776UA SG11201707776UA SG11201707776UA SG11201707776UA SG 11201707776U A SG11201707776U A SG 11201707776UA SG 11201707776U A SG11201707776U A SG 11201707776UA SG 11201707776U A SG11201707776U A SG 11201707776UA SG 11201707776U A SG11201707776U A SG 11201707776UA
Authority
SG
Singapore
Prior art keywords
administration
orally disintegrating
local anesthesia
fast acting
disintegrating film
Prior art date
Application number
SG11201707776UA
Inventor
Chien-Chiao Wang
Fang-Chu Lin
Catherine Lee
Original Assignee
Taho Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taho Pharmaceuticals Ltd filed Critical Taho Pharmaceuticals Ltd
Publication of SG11201707776UA publication Critical patent/SG11201707776UA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11201707776UA 2016-06-30 2016-06-30 A fast acting orally disintegrating film for administration of local anesthesia SG11201707776UA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2016/040228 WO2018004576A2 (en) 2016-06-30 2016-06-30 A fast acting orally disintegrating film for administration of local anesthesia

Publications (1)

Publication Number Publication Date
SG11201707776UA true SG11201707776UA (en) 2018-05-30

Family

ID=60786162

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201707776UA SG11201707776UA (en) 2016-06-30 2016-06-30 A fast acting orally disintegrating film for administration of local anesthesia

Country Status (9)

Country Link
US (1) US20180296495A1 (en)
EP (1) EP3478274A4 (en)
JP (1) JP2019523212A (en)
CN (1) CN107949378A (en)
AR (1) AR108897A1 (en)
AU (1) AU2016399462A1 (en)
RU (1) RU2018100879A (en)
SG (1) SG11201707776UA (en)
WO (1) WO2018004576A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2575625A (en) * 2018-06-22 2020-01-22 Church & Dwight Co Inc Oral care compositions comprising benzocaine and mucoadhesive thin films formed therefrom
SG11202100241UA (en) * 2018-07-11 2021-02-25 Cure Pharmaceutical Holding Corp Rapidly disintegrating oral film matrix
WO2020171727A2 (en) * 2019-02-19 2020-08-27 Bluepharma - Industria Farmacêutica, S.A. Mucoadhesive compositions and uses thereof
US12053447B2 (en) * 2019-06-25 2024-08-06 NuBioPharma, LLC Oral solution and powder to liquid compositions of balsalazide
CN110882166A (en) * 2019-12-10 2020-03-17 广州润虹医药科技股份有限公司 Stable calcium phosphate root canal filler

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1929819B (en) * 2004-01-30 2012-02-29 考里安国际公司 Fast Dissolving Films for Active Agent Delivery
BRPI0508359A (en) * 2004-03-03 2007-09-25 Warner Lambert Co film compositions
EP2134321A2 (en) * 2007-03-07 2009-12-23 Novartis Ag Orally administrable films
US9192572B2 (en) * 2012-01-02 2015-11-24 Andrew L. SKIGEN Oral anesthesia application
US20150104493A1 (en) * 2012-10-22 2015-04-16 Robert W. McDonald, III Dissolvable Strip for Treatment of Oral Thermal Burns
MX2017000137A (en) * 2014-06-24 2017-04-27 LEE Catherine Fast acting orally disintegrating film.
JP6467438B2 (en) * 2014-07-17 2019-02-13 ヘクサル・アクチェンゲゼルシャフトＨｅｘａｌ ＡＧ Orally disintegrating film

Also Published As

Publication number Publication date
EP3478274A4 (en) 2020-03-04
RU2018100879A3 (en) 2020-07-30
AU2016399462A1 (en) 2018-01-18
WO2018004576A2 (en) 2018-01-04
CN107949378A (en) 2018-04-20
US20180296495A1 (en) 2018-10-18
RU2018100879A (en) 2020-07-30
WO2018004576A3 (en) 2018-03-01
JP2019523212A (en) 2019-08-22
AR108897A1 (en) 2018-10-10
EP3478274A2 (en) 2019-05-08

Similar Documents

Publication Publication Date Title
NO2022046I1 (en) Berotralstat and pharmaceutically acceptable salts thereof
IL264210A (en) High-dose cannabinoid dosage forms for oral administration
EP3096763A4 (en) Novel process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof
PT3616696T (en) Orally administrable enzalutamide-containing pharmaceutical composition
SG11201707776UA (en) A fast acting orally disintegrating film for administration of local anesthesia
ZA201605103B (en) Administration of tasimelteon under fasted conditions
EP3106152A4 (en) Orally disintegrating tablet coated with film
HUE070095T2 (en) Orally disintegrating tablets
PT3449912T (en) Orally disintegrating tablet
SG11201610358XA (en) Fast acting orally disintegrating film
PT3446684T (en) Orally disintegrating tablet
EP3346996A4 (en) Oral pharmaceutical dosage forms of budesonide
PL3216599T3 (en) Liner film
ZA201608785B (en) Nasal administration
EP3092217A4 (en) A novel process for preparation of indacaterol or its pharmaceutically acceptable salts
ZA201703764B (en) Formulations of a pi3k/mtor-inhibitor for intravenous administration
EP3375438A4 (en) THREE-LAYER PREGABAL-CONTAINING RETARD TABLET FOR ORAL ADMINISTRATION
ZA201606653B (en) Solid forms of a pharmaceutically active compound
SMT202000120T1 (en) Multilayer tablet for administration of magnesium
ZA201900717B (en) Synthesis of (s)-2-amino-4-methyl-1-((r)-2-methyloxirane-2-yl)-pentan-1-one and pharmaceutically acceptable salts thereof
MX2017007510A (en) A process for the manufacture of idalopirdine.
HUP1600415A2 (en) Pimavanserin salts for the manufacture of pharmaceutical formulations
UA100326U (en) Use of sodium salt of hydrogen sulfide for potentiating analgesic effect of non-steroid anti-inflammatory drugs